Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities by Wahiba Oualikene-Gonin, Marie-Christine Jaulent, Jean-Pierre Thierry, Sofia Oliveira-Martins, Sofia Oliveira-Martins, Laetitia Belgodère, Patrick Maison, Patrick Maison, Patrick Maison, Joël Ankri, The Scientific Advisory Board of ANSM

Connect to this object online.

Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience by Laëtitia Belgodère, Joseph Emmerich, Joseph Emmerich, Nicolas Albin, Nicolas Albin, Trystan Bacon, Trystan Bacon, Trystan Bacon, Trystan Bacon, Pascale Daynes, Pascale Daynes, Stéphane Vignot, Stéphane Vignot, Thierry Vial, Thierry Vial, Guillaume Renaud, Carole Le Saulnier, Corine Maillard-Couvreur, Mélanie Cachet, Marie-Laure Veyries, Rym Youdarene, Wahiba Oualikene-Gonin, Christelle Ratignier-Carbonneil, Patrick Maison, Patrick Maison, Patrick Maison

Connect to this object online.

Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines... by Wahiba Oualikene-Gonin, Valérie Sautou, Eric Ezan, Henri Bastos, Eric Bellissant, Laëtitia Belgodère, Patrick Maison, Patrick Maison, Patrick Maison, Joël Ankri, The Scientific Advisory Board of the ANSM, Joël Ankri, Janine Barbot, Robert Barouki, Henri Bastos, Éric Bellissant, Christiane Druml, Éric Ezan, Didier Houssin, Walter Janssens, Marie-Christine Jaulent, Maria Emilia Monteiro, Dominique Pougheon, Vololona Rabeharisoa, Victoria Rollason, Valérie Sautou, Jean-Paul Vernant

Connect to this object online.